Target intelligence / Profile preview

G2E3 antisense RNA 1 (G2E3-AS1)

Target
G2E3-AS1
Molecular classification
Other (Long non-coding RNA), Natural antisense transcript
01

Overview

G2E3 antisense RNA 1 (G2E3-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the G2E3 gene locus. Antisense RNAs such as G2E3-AS1 are generally involved in the regulation of gene expression at transcriptional and post-transcriptional levels, frequently through RNA:RNA interactions, transcriptional interference, or chromatin modification at or near their locus of origin[2]. Most characterized antisense RNAs function locally (in cis) to modulate the expression of an overlapping protein-coding gene, but specific functions of G2E3-AS1 remain undocumented in the available literature. No pharmacological agents or therapeutic relevance are established for this transcript. The G2E3 gene itself encodes a ubiquitin ligase implicated in cell cycle regulation, but G2E3-AS1 is a distinct, non-coding entity.\n\nKey points clarifying this entry:\n- G2E3-AS1 is not a receptor, enzyme, transporter, or classical therapeutic target[2].\n- It is not a well-characterized RNA—no drugs or biomarker utility identified.\n- The target name, aliases, and abbreviations are correct for a lncRNA antisense transcript.\n- All canonical information (mechanistic, disease relevance, molecular classification) is supported by general antisense RNA literature, not by molecule-specific reports for G2E3-AS1.\n\nIf your aim is to annotate *protein-coding targets* (such as receptors or enzymes), **G2E3-AS1 does not fit** the standard definition and should be classified accordingly. If spatial or transcriptional regulation of G2E3 by G2E3-AS1 is later confirmed in primary literature, the above assessment should be updated.

Other names
CAT1647lincPRKDG2E3-AS1CAT1647 (duplicate; included for reference)lincPRKD (duplicate; included for reference)
02

Biological functions

Regulation of gene expression (putative, inferred based on antisense RNA literature)[2]Transcriptional interference (general NAT function, not confirmed for G2E3-AS1 specifically)[2]
03

Disease associations

Other (no direct evidence linking this RNA with specific diseases in current sources)

Beyond the preview

Go deeper on G2E3 antisense RNA 1 (G2E3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G2E3 antisense RNA 1 (G2E3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call